Product Information
NYSTATIN 100,000 UNIT/GM OINT is a generic product labeled by Actavis Pharma, Inc., priced at $0.2375 per GM under NDC 00472016630. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 13, 1987. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000 [USP'U]/g
Manufacturer
Actavis Pharma, Inc.NDC
00472016630
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA062840FDA Approved
11/13/1987
TE Code
AT
On Market Since
9/3/2002
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/GM OINT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2375 per GM |
|---|---|
| All-time high | $0.5532 (Apr 16, 2014) |
| All-time low | $0.1988 (May 22, 2024) |
| 52-week high | $0.2565 |
| 52-week low | $0.2323 |
| Median price | $0.3674 |
| Average price | $0.3680 |
| Largest weekly change | +22.6% (Feb 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/GM OINT?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/GM OINT, manufactured by Actavis Pharma, Inc., is $0.2375 per GM (NDC 00472016630), effective Sep 30, 2026.
How has the price of NYSTATIN 100,000 UNIT/GM OINT changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/GM OINT has declined 54.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/GM OINT?
Since Nov 28, 2013, the NADAC for NYSTATIN 100,000 UNIT/GM OINT has ranged from a low of $0.1988 (May 22, 2024) to a high of $0.5532 (Apr 16, 2014), with a median of $0.3674 per GM.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/GM OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/GM OINT, is $0.2331 per GM — about 2% below NYSTATIN 100,000 UNIT/GM OINT.
Who manufactures NYSTATIN 100,000 UNIT/GM OINT?
NYSTATIN 100,000 UNIT/GM OINT (NDC 00472016630) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.